• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实体瘤中肿瘤起始细胞的转移潜能。

Metastatic potential of tumor-initiating cells in solid tumors.

机构信息

Department of Genetics, Stanley S Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.

出版信息

Front Biosci (Landmark Ed). 2011 Jan 1;16(5):1927-38. doi: 10.2741/3831.

DOI:10.2741/3831
PMID:21196274
Abstract

The lethality of cancer is mainly caused by its properties of metastasis, drug resistance, and subsequent recurrence. Understanding the mechanisms governing these properties and developing novel strategies to overcome them will greatly improve the survival of cancer patients. Recent findings suggest that tumors are comprised of heterogeneous cell populations, and only a small fraction of these are tumorigenic with the ability to self-renew and produce phenotypically diverse tumor cell populations. Cells in this fraction are called tumor-initiating cells (TICs) or cancer stem cells (CSCs). TICs have been identified from many types of cancer. They share several similarities with normal adult stem cells including sphere-forming ability, self-renewability, and expression of stem cell surface markers and transcription factors. TICs have also been proposed to be responsible for cancer metastasis, however, scarce evidence for their metastatic potential has been provided. In this review article, we have attempted to summarize the studies which have examined the metastatic potential of TICs in solid tumors.

摘要

癌症的致命性主要是由其转移、耐药和随后复发的特性所导致的。了解这些特性的调控机制,并开发新的策略来克服它们,将极大地提高癌症患者的生存率。最近的研究结果表明,肿瘤由异质性细胞群体组成,只有一小部分具有肿瘤发生能力,能够自我更新并产生表型多样化的肿瘤细胞群体。这些细胞被称为肿瘤起始细胞(TICs)或癌症干细胞(CSCs)。TICs 已从多种类型的癌症中被鉴定出来。它们与正常成体干细胞有几个相似之处,包括球体形成能力、自我更新能力以及干细胞表面标志物和转录因子的表达。TICs 也被认为是癌症转移的原因,然而,关于它们转移潜力的证据很少。在这篇综述文章中,我们试图总结了研究 TICs 在实体瘤中转移潜力的研究。

相似文献

1
Metastatic potential of tumor-initiating cells in solid tumors.实体瘤中肿瘤起始细胞的转移潜能。
Front Biosci (Landmark Ed). 2011 Jan 1;16(5):1927-38. doi: 10.2741/3831.
2
CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance.CD117 和 Stro-1 鉴定与转移和耐药相关的骨肉瘤肿瘤起始细胞。
Cancer Res. 2010 Jun 1;70(11):4602-12. doi: 10.1158/0008-5472.CAN-09-3463. Epub 2010 May 11.
3
ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.ALDH 活性相对于 CD133 表达在人胰腺腺癌中选择性地定义了一个增强的肿瘤起始细胞群体。
PLoS One. 2011;6(6):e20636. doi: 10.1371/journal.pone.0020636. Epub 2011 Jun 13.
4
ABCG2 is a potential marker of tumor-initiating cells in breast cancer.ABCG2是乳腺癌中肿瘤起始细胞的一个潜在标志物。
Tumour Biol. 2015 Dec;36(12):9233-43. doi: 10.1007/s13277-015-3647-0. Epub 2015 Jun 20.
5
[Progress of cancer stem cells of solid tumor].[实体瘤癌症干细胞的研究进展]
Ai Zheng. 2006 Jun;25(6):775-8.
6
Identification of a subpopulation of long-term tumor-initiating cells in colon cancer.鉴定结肠癌中具有长期肿瘤起始能力的亚群细胞。
Biosci Rep. 2020 Aug 28;40(8). doi: 10.1042/BSR20200437.
7
Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation.通过使转移性乳腺癌细胞系反复暴露于缺氧和再氧化循环来鉴定干细胞样细胞群体。
Breast Cancer Res. 2010;12(6):R94. doi: 10.1186/bcr2773. Epub 2010 Nov 10.
8
Isolation, identification, and characterization of cancer stem cells: A review.癌症干细胞的分离、鉴定及特性分析:综述
J Cell Physiol. 2017 Aug;232(8):2008-2018. doi: 10.1002/jcp.25759. Epub 2017 Feb 28.
9
Pancreatic cancer stem cells.胰腺癌干细胞
J Clin Oncol. 2008 Jun 10;26(17):2806-12. doi: 10.1200/JCO.2008.16.6702.
10
Identifying and targeting tumor-initiating cells in the treatment of breast cancer.在乳腺癌治疗中识别并靶向肿瘤起始细胞。
Endocr Relat Cancer. 2015 Jun;22(3):R135-55. doi: 10.1530/ERC-14-0447. Epub 2015 Apr 15.

引用本文的文献

1
Advanced hierarchical computational modeling-based rational development of platinum (II) nanocomplex to improve lung cancer therapy.基于高级分层计算建模的铂(II)纳米复合物合理开发,以改善肺癌治疗。
Adv Funct Mater. 2025 Feb 12;35(7). doi: 10.1002/adfm.202411334. Epub 2024 Sep 27.
2
Role of STAT3 in pancreatic cancer.信号转导与转录激活因子3(STAT3)在胰腺癌中的作用。
Explor Target Antitumor Ther. 2024;5(5):20-34. doi: 10.37349/etat.2024.00202. Epub 2024 Jan 17.
3
miR‑122/SENP1 axis confers stemness and chemoresistance to liver cancer through Wnt/β‑catenin signaling.
miR-122/SENP1轴通过Wnt/β-连环蛋白信号通路赋予肝癌干性和化疗耐药性。
Oncol Lett. 2023 Jul 24;26(3):390. doi: 10.3892/ol.2023.13976. eCollection 2023 Sep.
4
ZNF32 promotes the self-renewal of colorectal cancer cells by regulating the LEPR-STAT3 signaling pathway.锌指蛋白 32 通过调控 LEPR-STAT3 信号通路促进结直肠癌细胞的自我更新。
Cell Death Dis. 2022 Feb 3;13(2):108. doi: 10.1038/s41419-022-04530-4.
5
Promotion of gastric tumor initiating cells in a 3D collagen gel culture model via YBX1/SPP1/NF-κB signaling.通过YBX1/SPP1/NF-κB信号通路在三维胶原凝胶培养模型中促进胃肿瘤起始细胞
Cancer Cell Int. 2021 Nov 10;21(1):599. doi: 10.1186/s12935-021-02307-x.
6
MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis.miR-454-3p 通过调控 Wnt/β-catenin 信号通路抑制物促进乳腺癌转移。
Theranostics. 2019 Jan 1;9(2):449-465. doi: 10.7150/thno.29055. eCollection 2019.
7
LSD1 modulates the non-canonical integrin β3 signaling pathway in non-small cell lung carcinoma cells.LSD1 调节非小细胞肺癌细胞中非经典整合素 β3 信号通路。
Sci Rep. 2017 Aug 31;7(1):10292. doi: 10.1038/s41598-017-09554-x.
8
Unsaturated fatty acids regulate stemness of ovarian cancer cells through NF-κB.不饱和脂肪酸通过核因子κB调控卵巢癌细胞的干性。
Stem Cell Investig. 2017 Jun 3;4:49. doi: 10.21037/sci.2017.05.07. eCollection 2017.
9
Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity.富集顺铂的癌症干细胞通过增强TRIB1/HDAC活性赋予非小细胞肺癌多药耐药性。
Cell Death Dis. 2017 Apr 13;8(4):e2746. doi: 10.1038/cddis.2016.409.
10
Suppressive roles of A3AR and TMIGD3 i1 in osteosarcoma malignancy.A3AR和TMIGD3 i1在骨肉瘤恶性肿瘤中的抑制作用。
Cell Cycle. 2017 May 19;16(10):903-904. doi: 10.1080/15384101.2017.1308153. Epub 2017 Mar 29.